SCHEMBL3097658

SCHEMBL3097658

O=C(O)C1CCCC(O)C1O

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PEPD P12955 1/20 0.43
MEN1 O00255 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
ACE P12821 1/20 0.35
GABRR1 P24046 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130226 1.00 PEPD (0.43) PEPDMEN1BLMKMT2AACE
SCHEMBL2034245 0.84
SCHEMBL5897097 0.84
SCHEMBL2692497 0.84
SCHEMBL3228170 0.84
SCHEMBL25347129 0.84 GABRR1 (0.43) MEN1KMT2AGABRR1
SCHEMBL2693338 0.84
SCHEMBL6559471 0.84
SCHEMBL3228177 0.84
SCHEMBL5897084 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4714426-A1 ACTIVE INGREDIENT FOR HAIR Miyoshi Oil & Fat Co., Ltd. (JP) 2026-03-25 EP disclosed
US-12441959-B2 Composition containing organic ammonium salt MIYOSHI OIL & FAT CO., LTD. (JP) 2025-10-14 US disclosed
US-12371632-B2 Additive or composition for imparting lubricity MIYOSHI OIL & FAT CO., LTD. (JP) 2025-07-29 US disclosed
US-20250186321-A1 FORMULATION USING AMINO ACID AND CARBOXYLIC ACID, ORGANIC SALT, AND COMPOSITION COMPRISING SAME AND USE THEREOF MIYOSHI OIL & FAT CO., LTD. (JP) 2025-06-12 US disclosed
US-20250090437-A1 COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF MIYOSHI YUSHI KK (JP) 2025-03-20 US disclosed
WO-2024237236-A1 ACTIVE INGREDIENT FOR HAIR ミヨシ油脂株式会社 2024-11-21 WO disclosed
US-20240271055-A1 ADDITIVE OR COMPOSITION FOR IMPARTING LUBRICITY MIYOSHI OIL & FAT CO., LTD. (JP) 2024-08-15 US disclosed
EP-4327889-A1 FORMULATION USING AMINO ACID AND CARBOXYLIC ACID, ORGANIC SALT, AND COMPOSITION COMPRISING SAME AND USE THEREOF Miyoshi Oil & Fat Co., Ltd. (JP) 2024-02-28 EP disclosed
US-20230340356-A1 ADDITIVE OR COMPOSITION FOR IMPARTING LUBRICITY MIYOSHI OIL & FAT CO., LTD. (JP) 2023-10-26 US disclosed
EP-3766969-B1 BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT MIYOSHI YUSHI KK (JP) 2023-10-04 EP disclosed
CN-101805748-A 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc BIOTICA TECH LTD 2010-08-18 CN disclosed
CN-100569944-C Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2009-12-16 CN disclosed
US-20090253732-A1 Production Of Polyketides And Other Natural Products BIOTICA TECHNOLOGY LIMITED 2009-10-08 US disclosed
US-20090239875-A1 Protection of ferulic acid and/or tetramethylpyrazine against retinal ischaemia, glaucoma and siderosis oculi COMMITTEE ON CHINESE MEDICINE AND PHARMACY, DEPARTMENT OF HEALTH, EXECUTIVE YUAN (TW) 2009-09-24 US disclosed
CN-101302550-A Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2008-11-12 CN disclosed
CN-1668741-A Production of polyketides and other natural products BIOTICA TECH LTD (GB) 2005-09-14 CN disclosed
CN-1351608-A 13-Methylerythromycin Derivatives PFIZER PROD INC (US) 2002-05-29 CN disclosed
CN-1316001-A Polyketides and their synthesis BIOTICA TECH LTD (GB) 2001-10-03 CN disclosed
CN-1315956-A Polyketides and their synthesis BIOTICA TECH LTD (GB) 2001-10-03 CN disclosed
EP-0002872-A1 Process for preparing acylated esters of hydroxy carboxylates THE PROCTER & GAMBLE COMPANY (US) 1979-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441959-B2 Composition containing organic ammonium salt SLC6A15, SLC38A7, SLC6A19 PEPD 3600/4885MEN1 4282/4885BLM 2393/4885
US-20250186321-A1 FORMULATION USING AMINO ACID AND CARBOXYLIC ACID, ORGANIC SALT, AND COMPOSITION COMPRISING SAME AND USE THEREOF SLC7A1, SLC38A7, CUTA PEPD 302/4885MEN1 3783/4885BLM 2557/4885
US-20090253732-A1 Production Of Polyketides And Other Natural Products PBK, IL15, IL17A PEPD 2156/4885MEN1 207/4885BLM 1451/4885
US-20250090437-A1 COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF CUTA, HAT1, NACA PEPD 4436/4885MEN1 643/4885BLM 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.